The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue

The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue

Pathogenesis and clinical manifestations of metabolic syndrome (and other conditions characterized by the growth of fat mass and decreased adiponectin content) is associated with an imbalance of sex hormones, which develops under the influence of increased aromatase activity in adipose tissue. Drugs...

Full description

Bibliographic Details
Main Authors:	D. V. Lytkin, A. L. Zagayko, T. O. Briukhanova
Format:	Article
Language:	English
Published:	Oles Honchar Dnipro National University 2018-08-01
Series:	Regulatory Mechanisms in Biosystems
Subjects:	exemestane; letrozole; anastrozole; adiponectin; metabolic syndrome
Online Access:	https://medicine.dp.ua/index.php/med/article/view/429

Similar Items

<i>In Vitro</i> Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
by: Patrícia H. A. Bezerra, et al.
Published: (2023-06-01)

A radiation recall phenomenon induced by aromatase inhibitors
by: Sabrine Slimani, et al.
Published: (2021-03-01)

The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
by: Alessandra Linardi, et al.

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
by: Javier García-Sánchez, et al.
Published: (2022-07-01)

Role of aromatase inhibitors in managing hypogonadism in adult males related to obesity and aging: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2022-01-01)

Long term effects of aromatase inhibitor treatment in patients with aromatase excess syndrome
by: Eleni Z. Giannopoulou, et al.
Published: (2024-11-01)

The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy
by: Nahid Punjani, MD, MPH, et al.
Published: (2021-08-01)

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC
by: Patricia A. Young, MD, et al.
Published: (2021-04-01)

Aromatase inhibitors in the treatment of deep endometriosis
by: Simone Ferrero, et al.
Published: (2009-09-01)

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
by: Yoo Jung Kim, et al.
Published: (2020-01-01)

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
by: Li Y, et al.
Published: (2020-06-01)

Pharmacological non-hormonal treatment options for male infertility: a systematic review and network meta-analysis
by: Bassel H. Al Wattar, et al.
Published: (2024-07-01)

The aromatase inhibitor letrozole enhances the effect of doxorubicin and docetaxel in an MCF7 cell line model
by: Mary O’Neill, et al.
Published: (2012-12-01)

Interaction of Zinc Chloride with an Aromatase Inhibitor (Letrozole) on Anxiety in Adult Male Rats
by: Sahar Charghan, et al.
Published: (2016-12-01)

Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
by: Yoshihito Morimoto, et al.
Published: (2017-11-01)

Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis
by: Tao He, et al.
Published: (2022-01-01)

Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy
by: Sandra Ledesma-Corvi, et al.
Published: (2023-10-01)

Effect Of A Non-Steroidal Aromatase Inhibitor On Ovarian Function And Synchronicity Of Estrus In Ewes At Subtropics
by: Abdel Dayem M. A., et al.
Published: (2020-10-01)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
by: Fionnuala Crowley, et al.
Published: (2022-04-01)

Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis
by: Xing Huang
Published: (2019-11-01)

An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER<sup>+</sup>) Breast Cancer: Effects on Sensitive and Resistant Cell Lines
by: Cristina Amaral, et al.
Published: (2023-01-01)

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022-03-01)

Effect of Letrozole Administration as a Selective Aromatase Inhibitor on Male Rat's Reproductive Performance
by: A Hmood Jassim, et al.
Published: (2022-02-01)

Cognitive Effects of Aromatase and Possible Role in Memory Disorders
by: Cheryl S. Rosenfeld, et al.
Published: (2018-10-01)

Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor
by: Melissa Schwartz, et al.
Published: (2016-01-01)

Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
by: Viktoria Knöbl, et al.
Published: (2024-10-01)

Aromatase inhibitors can improve the semen quality of aged roosters by up regulating genes related to steroid hormone synthesis
by: Xuliang Luo, et al.
Published: (2024-12-01)

Effect of Aromatase Inhibitor Letrozole on the Placenta of Adult Albino Rats: A Histopathological, Immunohistochemical, and Biochemical Study
by: Mohamed Ali Alabiad, et al.
Published: (2024-01-01)

Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report
by: Omar F. Altal, et al.
Published: (2021-05-01)

Effects of the aromatase inhibitor Letrozole on serum immunoglobulin and lysozyme levels in immunized rainbow trout (Oncorhynchus mykiss Walbaum) females
by: Paria Akbary, et al.
Published: (2013-12-01)

Comparison of gonadotropin releasing hormone agonists (GNRHA) vs aromatase inhibitors on volume of uterine leiomyomas in premenopausal women
by: Uzma Hussain, et al.
Published: (2023-12-01)

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
by: C.C. Hack, et al.
Published: (2020-04-01)

Effect of aromatase inhibitors for preventing ovarian hyperstimulation syndrome in infertile patients undergoing in vitro fertilization: a systematic review and meta-analysis
by: Linying Jiang, et al.
Published: (2024-07-01)

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial
by: Pamela M. J. McLaughlin, et al.
Published: (2022-05-01)

Design of Novel Letrozole Analogues Targeting Aromatase for Breast Cancer: Molecular Docking, Molecular Dynamics, and Theoretical Studies on Gold Nanoparticles
by: Alaa Edris, et al.
Published: (2023-04-01)

Determination of Exemestane in bulk and pharmaceutical dosage form by HPTLC
by: Maya B. Mane, et al.
Published: (2014-09-01)

Locomotion Outcome Improvement in Mice with Glioblastoma Multiforme after Treatment with Anastrozole
by: Irene Guadalupe Aguilar-García, et al.
Published: (2023-03-01)

Chlorogenic Acid Restores Ovarian Functions in Mice with Letrozole-Induced Polycystic Ovarian Syndrome Via Modulation of Adiponectin Receptor
by: Mohd Zahoor ul Haq Shah, et al.
Published: (2023-03-01)

Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy
by: Sarah Mokhtar, et al.
Published: (2022-03-01)

Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma
by: Heather Wolfe, et al.
Published: (2016-01-01)